Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2011 Jul;49(7):2590-3.
doi: 10.1128/JCM.02402-10. Epub 2011 May 4.

RNA versus DNA (NucliSENS EasyQ HIV-1 v1.2 versus Amplicor HIV-1 DNA test v1.5) for early diagnosis of HIV-1 infection in infants in Senegal

K Kébé  1 , O Ndiaye, H Diop Ndiaye, P Mbakob Mengue, P M M Guindo, S Diallo, N Léye, S B Gueye, A Gaye Diallo, C Touré Kane, S Mboup
Affiliations
Comparative Study

RNA versus DNA (NucliSENS EasyQ HIV-1 v1.2 versus Amplicor HIV-1 DNA test v1.5) for early diagnosis of HIV-1 infection in infants in Senegal

K Kébé et al. J Clin Microbiol. 2011 Jul.

Abstract

The objective of this study was to compare the performance of the NucliSENS EasyQ HIV-1 v1.2 platform (bioMérieux, France) to the Amplicor HIV-1 DNA test v1.5 (Roche Molecular Systems, Switzerland) in detecting HIV-1 infection in infants using venipuncture-derived whole blood in tubes and dried blood spots. A total of 149 dried blood spots and 43 EDTA-anticoagulated peripheral blood samples were collected throughout Dakar and other areas in Senegal from infants and children aged 3 weeks to 24 months who were born to HIV-1-infected mothers. Samples were tested using the NucliSENS and Amplicor technologies. The NucliSENS and Amplicor results were 100% concordant using either EDTA-anticoagulated peripheral blood or dried blood spots. Compared to Amplicor, the sensitivity and specificity of the NucliSENS test were 100%. The NucliSENS EasyQ HIV-1 RNA assay performed as well as the Amplicor HIV-1 DNA test in detecting HIV-1 infection in infants. In addition, this platform can give an indication of the viral load baseline. The NucliSENS EasyQ platform is a good alternative for early infant diagnosis of HIV-1 infection.

PubMed Disclaimer

References

    1. Cassol S., et al. 1994. Rapid screening for early detection of mother-to-child transmission of human immunodeficiency virus type 1. J. Clin. Microbiol. 32:2641–2645 - PMC - PubMed
    1. Cassol S. A., et al. 1992. Diagnosis of vertical HIV-1 transmission using the polymerase chain reaction and dried blood spot specimens. J. Acquir. Immune Defic. Syndr. 5:113–119 - PubMed
    1. Comeau A. M., et al. 1992. Polymerase chain reaction in detecting HIV infection among seropositive infants: relation to clinical status and age and to results of other assays. J. Acquir. Immune Defic. Syndr. 5:271–278 - PubMed
    1. Creek T. L., et al. 2007. Infant human immunodeficiency virus diagnosis in resource-limited settings: issues, technologies, and country experiences. Am. J. Obstet. Gynecol. 197:S64–S71 - PubMed
    1. Cunningham C. K., et al. 1999. Comparison of human immunodeficiency virus 1 DNA polymerase chain reaction and qualitative and quantitative RNA polymerase chain reaction in human immunodeficiency virus 1-exposed infants. Pediatr. Infect. Dis. J. 8:30–35 - PubMed

Publication types

MeSH terms